Finance

Beta
Lists
AGMB:NASDAQ
Agomab Therapeutics NV
12,65 $
+6,57%
(+0,78) 1D
2 հլս, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AGMB...
Open
11,88 $
High
13,13 $
Low
11,88 $
Mkt. cap
622,99 մլն
Avg. vol.
108,03 հզր
Volume
38,86 հզր
52-wk high
17,82 $
52-wk low
8,75 $
EPS
-1,46 $
No. of employees
62
Open
11,88 $
High
13,13 $
Low
11,88 $
Mkt. cap
622,99 մլն
Avg. vol.
108,03 հզր
Volume
38,86 հզր
52-wk high
17,82 $
52-wk low
8,75 $
EPS
-1,46 $
No. of employees
62
News stories
From sources across the web
About Agomab Therapeutics NV
CEO-
Employees62
Founded2017
Headquarters-
Sector-
Websiteagomab.com
Analyst ratings
Based on 2 analysts giving stock ratings to AGMB in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for AGMB in the last 3 months.
Highest
Current 12,65 $
35,00 $ (+176,68%)
Average
22,78 $ (+80,08%)
Lowest
10,55 $ (-16,60%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Initiated
35,00 $
+176,7%
06/22/2026
Judah Frommer
Morgan Stanley
Buy
Maintained
10,55 $
-16,6%
05/18/2026
Anupam Rama
J.P. Morgan
Buy
Initiated
32,00 $
+153%
03/03/2026
Thomas Smith
Leerink Partners
Buy
Initiated
36,00 $
+184,6%
03/03/2026
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
2024 թ. դեկ
2025 թ. դեկ
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
10,73 մլն
13,86 մլն
Total research and development expenses
-
-
Selling, general, and admin expenses
1,47 մլն
3,17 մլն
Operating expense
11,81 մլն
16,53 մլն
Total operating expenses
11,81 մլն
16,53 մլն
Operating income
-11,81 մլն
-16,53 մլն
Other non operating income
-309,00 հզր
-1,54 մլն
EBT including unusual items
-11,73 մլն
-17,40 մլն
EBT excluding unusual items
-11,73 մլն
-17,40 մլն
Income tax expense
4,00 հզր
-
Effective tax rate
-0,03%
-
Other operating expenses
-383,00 հզր
-506,00 հզր
Net income
-11,73 մլն
-17,40 մլն
Net profit margin
-
-
Earnings per share
-
-
Interest and investment income
626,00 հզր
720,00 հզր
Interest expense
-
-
Net interest expenses
626,00 հզր
720,00 հզր
Depreciation and amortization charges
-
-
EBITDA
-11,80 մլն
-16,51 մլն
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer